|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/12 | (2006.01) |
| C07D 239/94 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 3521282 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18213309.0 |
| Date of filing the European patent application | 2015-12-23 | |
| (97) | Date of publication of the European application | 2019-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation | 2021-11-25 |
| (30) | Number | Date | Country code |
| 201462096748 P | 2014-12-24 | US |
| (72) |
JANSA, Petr , US
SIMON, Petr , CZ
LANSDON, Eric , US
HU, Yunfeng Eric , US
BASZCZYNSKI, Ondrej , CZ
DEJMEK, Milan , CZ
MACKMAN, Richard, L. , US
|
| (73) |
Gilead Sciences, Inc. ,
333 Lakeside Drive, Foster City, CA 94404,
US
Institute of Organic Chemistry and Biochemistry AS CR, V.V.I. , Flemingovo nam. 2, 16610 Praha 6, CZ |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Chinazolino dariniai, naudojami ŽIV gydymui |
| QUINAZOLINE DERIVATIVES USED TO TREAT HIV |
| Payment date | Validity (years) | Amount | |
| 2024-12-20 | 10 | 231.00 EUR |
| 2025-12-23 |